Abstract Book for the 9th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2018)

Posted On 2018-10-25 09:30:40
Oral Abstract Session 1
AB001. OA01.01: Tumor size as a prognostic factor in limited stage thymic epithelial tumors: a multicenter analysis
Jae Kwang Yun1, Hyeong Ryul Kim1, Geun Dong Lee1, Su Kyung Hwang1, Se Hoon Choi1, Yong-Hee Kim1, Dong Kwan Kim1, Seung-Il Park1, Jae Jun Jung2, Sumin Shin2, Jong Ho Cho2, Hong Kwan Kim2, Yong Soo Choi2, Jhingook Kim2, Jae Il Zo2, Young Mog Shim2, Samina Park3, Kwan Yong Hyun3, Yoohwa Hwang3, Hyun Joo Lee3, In Kyu Park3, Chang Hyun Kang3, Young Tae Kim3, Chang Young Lee4, Jin Gu Lee4, Hyo Chae Paik4, Dae Joon Kim4, Kyoung Young Chung4
PDF ABSTRACT
Oral Abstract Session 1
AB002. OA01.02: Modified subxiphoid thoracoscopic versus unilateral thoracoscopic approach for early-stage thymomas without myasthenia gravis
Jianyong Ding, Hao Wang, Li-Jie Tan, Qun Wang
PDF ABSTRACT
Oral Abstract Session 1
AB003. OA01.03: Comparison of two assessment criteria for thymic epithelial tumors after chemoradiotherapy
Kailiang Wu, Xingwen Fan, Yu Yang, Hongbing Wang
PDF ABSTRACT
Oral Abstract Session 1
AB004. OA01.04: Predictors of occult pleural dissemination detected intraoperatively in patients with thymic tumors
Weigang Zhao, Yi Yang
PDF ABSTRACT
Oral Abstract Session 1
AB005. OA01.05: Prognostic factor of T3N0M0 thymic epithelial tumor with complete resection
Yi-Ting Yen, Chao-Chun Chang, Ying-Yuan Chen, Wei-Li Huang, Yau-Lin Tseng
PDF ABSTRACT
Oral Abstract Session 1
AB006. OA01.06: Incidence and pathological features of thymomatous myasthenia gravis after thymectomy at a tertiary-level center
Arthur Vieira1, Dorsa Mousadoust2, John Yee1, Anna Mcguire1
PDF ABSTRACT
Oral Abstract Session 1
AB007. OA01.07: CD70 in thymic carcinoma: a promising diagnostic marker
Jumpei Kashima, Tsunekazu Hishima, Yusuke Okuma, Masumi Ogawa, Yukiko Hayashi, Shin-Ichro Horiguchi, Akiko Tonooka, Toru Motoi, Hirotoshi Horio
PDF ABSTRACT
Oral Abstract Session 1
AB008. OA01.08: Thymic carcinoma: preliminary data of next generation sequencing analysis
Beatrice Casini1, Diletta Sarti1, Enzo Gallo1, Gabriele Alessandrini2, Fabiana Cecere3, Edoardo Pescarmona1, Francesco Facciolo2, Mirella Marino1
PDF ABSTRACT
Oral Abstract Session 1
AB009. OA01.09: Gene expression profile reveals new biomarker for novel diagnosis and therapy in thymic and pulmonary carcinomas
Djeda Belharazem1, Michael Kuhn1, Berthold Schalke2, Peter Hohenberger3, Alexander Marx1
PDF ABSTRACT
Oral Abstract Session 2
AB010. OA02.01: Comparison of factors affecting length of stay after surgery for thymic tumors: minimally invasive vs. open surgeries
Kwon Joong Na, Samina Park, In Kyu Park, Young Tae Kim, Chang Hyun Kang
PDF ABSTRACT
Oral Abstract Session 2
AB011. OA02.02: The importance of measuring acetylcholine receptor antibodies in thymomas
Florit Marcuse1, Monique Hochstenbag2, Janneke Hoeijmakers3, Jos Maessen1, Marc De Baets4
PDF ABSTRACT
Oral Abstract Session 2
AB012. OA02.03: Adjuvant chemotherapy improved survival of completely resected thymic squamous cell carcinoma
Lanting Gao, Changlu Wang
PDF ABSTRACT
Oral Abstract Session 2
AB013. OA02.04: MRI for the follow-up of treated thymic epithelial malignancies
Ariel Kerpel, Edith M. Marom
PDF ABSTRACT
Oral Abstract Session 2
AB014. OA02.05: The role of postoperative radiotherapy in stage II and III thymoma: a Korean multicenter database study
Seung Hwan Song1, Jee Won Suh1, Woo Sik Yu1, Go Eun Byun1, Seong Yong Park1, Chang Young Lee1, Jin Gu Lee1, Dae Joon Kim1, Hyo Chae Paik1, Geun Dong Lee2, Se Hoon Choi2, Hyeong Ryul Kim2, Yong-Hee Kim2, Dong Kwan Kim2, Seung-Il Park2, Samina Park3, Yoohwa Hwang3, In Kyu Park3, Chang Hyun Kang3, Young Tae Kim3, Jong Ho Cho4, Hong Kwan Kim4, Yong Soo Choi4, Jhingook Kim4, Jae Il Zo4, Young Mog Shim4, Kyoung Young Chung1
PDF ABSTRACT
Oral Abstract Session 2
AB015. OA02.06: A dosimetric comparison of VMAT and IMPT with and without aperture for thymic cancer
Kwanghyun Jo, Dongryul Oh, Hongryul Pyo, Yong Chan Ahn, Sang Gyu Ju, Kwangzoo Chung, Eunah Chung, Seyjhoon Park, Woojin Lee, Jinman Kim, Jae Myoung Noh
PDF ABSTRACT
Lecture Abstract
AB016. LA01. Impact of lymph node dissection on thymic malignancy: The Korean Association for Research on the Thymus (KART) Database Study
Yoohwa Hwang
PDF ABSTRACT
Lecture Abstract
AB017. LA02. Minimally invasive surgery of thymic tumors
Geun Dong Lee
PDF ABSTRACT
Lecture Abstract
AB018. LA03. Technical advances of radiotherapy for thymic epithelial tumors
Jae Myoung Noh
PDF ABSTRACT
Lecture Abstract
AB019. LA04. Approach to the prevascular mass
Noriyuki Tomiyama
PDF ABSTRACT
Lecture Abstract
AB020. LA05. Determining extent of invasion and follow-up of thymic epithelial malignancies
Marcelo Benveniste
PDF ABSTRACT
Lecture Abstract
AB021. LA06. Management of the incidentally detected prevascular mass
Soon Ho Yoon
PDF ABSTRACT
Lecture Abstract
AB022. LA07. Is there a threshold for getting over the learning curve for minimally invasive surgery for thymoma?
Joshua R. Sonett
PDF ABSTRACT
Lecture Abstract
AB023. LA08. Using CUSUM for monitoring a new program
Nuria M. Novoa
PDF ABSTRACT
Lecture Abstract
AB024. LA09. What extent of node sampling or dissection is appropriate?
In Kyu Park
PDF ABSTRACT
Lecture Abstract
AB025. LA10. Difficulties in node assessment with minimally invasive surgery and potential solutions
Takashi Suda
PDF ABSTRACT
Lecture Abstract
AB026. LA11. Thymic malignancies tumor board: medical oncology
Nicolas Girard1,2
PDF ABSTRACT
Lecture Abstract
AB027. LA12. Surgery and Intrapleural therapy for stage IVa thymic tumors
Sukki Cho
PDF ABSTRACT
Lecture Abstract
AB028. LA13. Management of stage IVa thymoma: Shanghai Chest experience
Changlu Wang1, Lanting Gao1, Wentao Fang2 Yu Zhang
PDF ABSTRACT